True Wealth Design
MIRM icon

True Wealth Design’s Mirum Pharmaceuticals MIRM Stock Holding History

True Wealth Design’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.07K Buy
71
+1
+1% +$104 ﹤0.01% 1271
2026
Q2 		$8.2K Hold
70
– – ﹤0.01% 1139
2026
Q1 		$6.47K Hold
70
– – ﹤0.01% 1115
2025
Q4 		$5.53K Hold
70
– – ﹤0.01% 1047
2025
Q3 		$5.13K Hold
70
– – ﹤0.01% 1073
2025
Q2 		$3.56K Buy
70
+66
+1,650% +$2.94K ﹤0.01% 948
2025
Q1 		$181 Buy
+4
New +$189 ﹤0.01% 1994

Other funds holding MIRM

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Secure Asset Management
Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Contravisory Investment Management
Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
WIA
Wetzel Investment Advisors Indianapolis, Indiana $290M AUM 16.64% 1-Year Est. Return

True Wealth Design's MIRM Position: Q3 2026 in Review

True Wealth Design increased its Mirum Pharmaceuticals (MIRM) stake by 1.4% in Q3 2026, buying an estimated $104 and bringing the position to 71 shares worth $6.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1271.

True Wealth Design first reported a position in MIRM in Q1 2025 and has held it in 7 quarters since. The position peaked at $8.2K in Q2 2026. 33 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • True Wealth Design held 71 shares of Mirum Pharmaceuticals worth $6.07K as of Q3 2026.
  • True Wealth Design bought 1 Mirum Pharmaceuticals share in Q3 2026, an estimated $104.
  • Mirum Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1271 holding.
  • True Wealth Design first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • True Wealth Design's Mirum Pharmaceuticals position peaked at $8.2K in Q2 2026.
  • 33 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.